Nano-Hydroxyapatite Modulates Osteoblast Differentiation Through Autophagy Induction via mTOR Signaling Pathway
Hydroxyapatite (HAP) plays an important role in skeleton formation and bone remodeling. Synthetic HAP is similar to naturally occurring HAP and has been widely used in orthopedic and dental implantation. While it is known nano-HAP easily aggregates at high concentrations, the intracellular
fate and mechanisms-of-action of dispersed nano-HAP in osteoblast differentiation remain to be fully elucidated. In the present study, we treated the osteoblast cell line MC3T3E1 with autoclaved nano-HAP and added sodium hexametaphosphate to control nanoparticle agglomeration. Dispersed nano-HAP
promoted osteoblast differentiation in a dose-dependent manner. Our findings further revealed that the internalized nano-HAP particles were located in typical autophagic vacuoles and increased the ratio of LC3II/LC3I, indicating nano-HAP induced cell autophagy. Moreover, the induction of autophagy
by nano-HAP was via mTOR signaling pathway which also concentration dependent. Collectively, these results reveal nano-HAP modulates osteoblast differentiation by mediating autophagy in a dose-dependent manner.
Keywords: AGGLOMERATION; AUTOPHAGY; HYDROXYAPATITE NANOPARTICLES; MTOR SIGNALING PATHWAY; OSTEOBLAST DIFFERENTIATION
Document Type: Research Article
Publication date: 01 February 2019
- Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content